Are There Hidden Genes in DNA/RNA Vaccines?

Due to the fast global spreading of the Severe Acute Respiratory Syndrome Coronavirus – 2 (SARS-CoV-2), prevention and treatment options are direly needed in order to control infection-related morbidity, mortality, and economic losses. Although drug and inactivated and attenuated virus vaccine devel...

Full description

Bibliographic Details
Main Authors: Christopher A. Beaudoin, Martin Bartas, Adriana Volná, Petr Pečinka, Tom L. Blundell
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.801915/full
_version_ 1819284501382037504
author Christopher A. Beaudoin
Martin Bartas
Adriana Volná
Petr Pečinka
Tom L. Blundell
author_facet Christopher A. Beaudoin
Martin Bartas
Adriana Volná
Petr Pečinka
Tom L. Blundell
author_sort Christopher A. Beaudoin
collection DOAJ
description Due to the fast global spreading of the Severe Acute Respiratory Syndrome Coronavirus – 2 (SARS-CoV-2), prevention and treatment options are direly needed in order to control infection-related morbidity, mortality, and economic losses. Although drug and inactivated and attenuated virus vaccine development can require significant amounts of time and resources, DNA and RNA vaccines offer a quick, simple, and cheap treatment alternative, even when produced on a large scale. The spike protein, which has been shown as the most antigenic SARS-CoV-2 protein, has been widely selected as the target of choice for DNA/RNA vaccines. Vaccination campaigns have reported high vaccination rates and protection, but numerous unintended effects, ranging from muscle pain to death, have led to concerns about the safety of RNA/DNA vaccines. In parallel to these studies, several open reading frames (ORFs) have been found to be overlapping SARS-CoV-2 accessory genes, two of which, ORF2b and ORF-Sh, overlap the spike protein sequence. Thus, the presence of these, and potentially other ORFs on SARS-CoV-2 DNA/RNA vaccines, could lead to the translation of undesired proteins during vaccination. Herein, we discuss the translation of overlapping genes in connection with DNA/RNA vaccines. Two mRNA vaccine spike protein sequences, which have been made publicly-available, were compared to the wild-type sequence in order to uncover possible differences in putative overlapping ORFs. Notably, the Moderna mRNA-1273 vaccine sequence is predicted to contain no frameshifted ORFs on the positive sense strand, which highlights the utility of codon optimization in DNA/RNA vaccine design to remove undesired overlapping ORFs. Since little information is available on ORF2b or ORF-Sh, we use structural bioinformatics techniques to investigate the structure-function relationship of these proteins. The presence of putative ORFs on DNA/RNA vaccine candidates implies that overlapping genes may contribute to the translation of smaller peptides, potentially leading to unintended clinical outcomes, and that the protein-coding potential of DNA/RNA vaccines should be rigorously examined prior to administration.
first_indexed 2024-12-24T01:48:23Z
format Article
id doaj.art-04fce1eb78dc496c94f60c9e8e4696f1
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-24T01:48:23Z
publishDate 2022-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-04fce1eb78dc496c94f60c9e8e4696f12022-12-21T17:21:47ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-02-011310.3389/fimmu.2022.801915801915Are There Hidden Genes in DNA/RNA Vaccines?Christopher A. Beaudoin0Martin Bartas1Adriana Volná2Petr Pečinka3Tom L. Blundell4Department of Biochemistry, Sanger Building, University of Cambridge, Cambridge, United KingdomDepartment of Biology and Ecology, University of Ostrava, Ostrava, CzechiaDepartment of Physics, University of Ostrava, Ostrava, CzechiaDepartment of Biology and Ecology, University of Ostrava, Ostrava, CzechiaDepartment of Biochemistry, Sanger Building, University of Cambridge, Cambridge, United KingdomDue to the fast global spreading of the Severe Acute Respiratory Syndrome Coronavirus – 2 (SARS-CoV-2), prevention and treatment options are direly needed in order to control infection-related morbidity, mortality, and economic losses. Although drug and inactivated and attenuated virus vaccine development can require significant amounts of time and resources, DNA and RNA vaccines offer a quick, simple, and cheap treatment alternative, even when produced on a large scale. The spike protein, which has been shown as the most antigenic SARS-CoV-2 protein, has been widely selected as the target of choice for DNA/RNA vaccines. Vaccination campaigns have reported high vaccination rates and protection, but numerous unintended effects, ranging from muscle pain to death, have led to concerns about the safety of RNA/DNA vaccines. In parallel to these studies, several open reading frames (ORFs) have been found to be overlapping SARS-CoV-2 accessory genes, two of which, ORF2b and ORF-Sh, overlap the spike protein sequence. Thus, the presence of these, and potentially other ORFs on SARS-CoV-2 DNA/RNA vaccines, could lead to the translation of undesired proteins during vaccination. Herein, we discuss the translation of overlapping genes in connection with DNA/RNA vaccines. Two mRNA vaccine spike protein sequences, which have been made publicly-available, were compared to the wild-type sequence in order to uncover possible differences in putative overlapping ORFs. Notably, the Moderna mRNA-1273 vaccine sequence is predicted to contain no frameshifted ORFs on the positive sense strand, which highlights the utility of codon optimization in DNA/RNA vaccine design to remove undesired overlapping ORFs. Since little information is available on ORF2b or ORF-Sh, we use structural bioinformatics techniques to investigate the structure-function relationship of these proteins. The presence of putative ORFs on DNA/RNA vaccine candidates implies that overlapping genes may contribute to the translation of smaller peptides, potentially leading to unintended clinical outcomes, and that the protein-coding potential of DNA/RNA vaccines should be rigorously examined prior to administration.https://www.frontiersin.org/articles/10.3389/fimmu.2022.801915/fullSARS-CoV-2spike proteinDNA vaccineRNA vaccineORF2bORF-Sh
spellingShingle Christopher A. Beaudoin
Martin Bartas
Adriana Volná
Petr Pečinka
Tom L. Blundell
Are There Hidden Genes in DNA/RNA Vaccines?
Frontiers in Immunology
SARS-CoV-2
spike protein
DNA vaccine
RNA vaccine
ORF2b
ORF-Sh
title Are There Hidden Genes in DNA/RNA Vaccines?
title_full Are There Hidden Genes in DNA/RNA Vaccines?
title_fullStr Are There Hidden Genes in DNA/RNA Vaccines?
title_full_unstemmed Are There Hidden Genes in DNA/RNA Vaccines?
title_short Are There Hidden Genes in DNA/RNA Vaccines?
title_sort are there hidden genes in dna rna vaccines
topic SARS-CoV-2
spike protein
DNA vaccine
RNA vaccine
ORF2b
ORF-Sh
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.801915/full
work_keys_str_mv AT christopherabeaudoin aretherehiddengenesindnarnavaccines
AT martinbartas aretherehiddengenesindnarnavaccines
AT adrianavolna aretherehiddengenesindnarnavaccines
AT petrpecinka aretherehiddengenesindnarnavaccines
AT tomlblundell aretherehiddengenesindnarnavaccines